181 related articles for article (PubMed ID: 36231023)
1. Restored Fyn Levels in Huntington's Disease Contributes to Enhanced Synaptic GluN2B-Composed NMDA Receptors and CREB Activity.
Fão L; Coelho P; Rodrigues RJ; Rego AC
Cells; 2022 Sep; 11(19):. PubMed ID: 36231023
[No Abstract] [Full Text] [Related]
2. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
[TBL] [Abstract][Full Text] [Related]
3. Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model.
Gladding CM; Sepers MD; Xu J; Zhang LY; Milnerwood AJ; Lombroso PJ; Raymond LA
Hum Mol Genet; 2012 Sep; 21(17):3739-52. PubMed ID: 22523092
[TBL] [Abstract][Full Text] [Related]
4. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.
Fan J; Gladding CM; Wang L; Zhang LY; Kaufman AM; Milnerwood AJ; Raymond LA
Neurobiol Dis; 2012 Mar; 45(3):999-1009. PubMed ID: 22198502
[TBL] [Abstract][Full Text] [Related]
5. Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice.
Dau A; Gladding CM; Sepers MD; Raymond LA
Neurobiol Dis; 2014 Feb; 62():533-42. PubMed ID: 24269729
[TBL] [Abstract][Full Text] [Related]
6. Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.
Gladding CM; Fan J; Zhang LY; Wang L; Xu J; Li EH; Lombroso PJ; Raymond LA
J Neurochem; 2014 Jul; 130(1):145-59. PubMed ID: 24588402
[TBL] [Abstract][Full Text] [Related]
7. Altered Regulation of Striatal Neuronal
Kang R; Wang L; Sanders SS; Zuo K; Hayden MR; Raymond LA
Front Synaptic Neurosci; 2019; 11():3. PubMed ID: 30846936
[No Abstract] [Full Text] [Related]
8. CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content.
Boussicault L; Kacher R; Lamazière A; Vanhoutte P; Caboche J; Betuing S; Potier MC
Biochimie; 2018 Oct; 153():70-79. PubMed ID: 30107216
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of Tyrosine 1070 at the GluN2B Subunit Is Regulated by Synaptic Activity and Critical for Surface Expression of N-Methyl-D-aspartate (NMDA) Receptors.
Lu W; Fang W; Li J; Zhang B; Yang Q; Yan X; Peng L; Ai H; Wang JJ; Liu X; Luo J; Yang W
J Biol Chem; 2015 Sep; 290(38):22945-54. PubMed ID: 26229100
[TBL] [Abstract][Full Text] [Related]
10. GluN3A promotes NMDA spiking by enhancing synaptic transmission in Huntington's disease models.
Mahfooz K; Marco S; Martínez-Turrillas R; Raja MK; Pérez-Otaño I; Wesseling JF
Neurobiol Dis; 2016 Sep; 93():47-56. PubMed ID: 27072890
[TBL] [Abstract][Full Text] [Related]
11. Opposing roles of synaptic and extrasynaptic NMDA receptor signaling in cocultured striatal and cortical neurons.
Kaufman AM; Milnerwood AJ; Sepers MD; Coquinco A; She K; Wang L; Lee H; Craig AM; Cynader M; Raymond LA
J Neurosci; 2012 Mar; 32(12):3992-4003. PubMed ID: 22442066
[TBL] [Abstract][Full Text] [Related]
12. Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease.
Fan J; Cowan CM; Zhang LY; Hayden MR; Raymond LA
J Neurosci; 2009 Sep; 29(35):10928-38. PubMed ID: 19726651
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A.
Metzler M; Gan L; Mazarei G; Graham RK; Liu L; Bissada N; Lu G; Leavitt BR; Hayden MR
J Neurosci; 2010 Oct; 30(43):14318-29. PubMed ID: 20980587
[TBL] [Abstract][Full Text] [Related]
14. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
15. Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.
Cowan CM; Fan MM; Fan J; Shehadeh J; Zhang LY; Graham RK; Hayden MR; Raymond LA
J Neurosci; 2008 Nov; 28(48):12725-35. PubMed ID: 19036965
[TBL] [Abstract][Full Text] [Related]
16. DAPK1 Promotes Extrasynaptic GluN2B Phosphorylation and Striatal Spine Instability in the YAC128 Mouse Model of Huntington Disease.
Schmidt ME; Caron NS; Aly AE; Lemarié FL; Dal Cengio L; Ko Y; Lazic N; Anderson L; Nguyen B; Raymond LA; Hayden MR
Front Cell Neurosci; 2020; 14():590569. PubMed ID: 33250715
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.
Wu J; Ryskamp DA; Liang X; Egorova P; Zakharova O; Hung G; Bezprozvanny I
J Neurosci; 2016 Jan; 36(1):125-41. PubMed ID: 26740655
[TBL] [Abstract][Full Text] [Related]
18. Restoration of c-Src/Fyn Proteins Rescues Mitochondrial Dysfunction in Huntington's Disease.
Fão L; Coelho P; Duarte L; Vilaça R; Hayden MR; Mota SI; Rego AC
Antioxid Redox Signal; 2023 Jan; 38(1-3):95-114. PubMed ID: 35651273
[No Abstract] [Full Text] [Related]
19. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects.
Vizi ES; Kisfali M; Lőrincz T
Brain Res Bull; 2013 Apr; 93():32-8. PubMed ID: 23089362
[TBL] [Abstract][Full Text] [Related]
20. Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease.
Li L; Murphy TH; Hayden MR; Raymond LA
J Neurophysiol; 2004 Nov; 92(5):2738-46. PubMed ID: 15240759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
